Manufacturer:

          Sanofi-Aventis.

Contents:

          Clopidogrel hydrogen sulfate

Indications:

          Prevention of atherothrombotic events in patients suffering from MI (from a few days until <35 days), ischaemic stroke (from 7 days until <6 mth) or established peripheral arterial disease; patients suffering from non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave MI), including patients undergoing a stent placement following percutaneous coronary intervention in combination w/ acetylsalicylic acid (ASA); ST segment elevation acute MI, in combination w/ ASA in medically-treated patients eligible for thrombolytic therapy.

Contraindications:

          Severe liver impairment. Peptic ulcer & intracranial haemorrhage. Lactation.

Special Precautions:

          Patients who may be at risk of increased bleeding from trauma, surgery or other pathological conditions. Patients w/ moderate hepatic disease who may have bleeding diatheses. Pregnancy.

Dosage:

          Adult & the elderly 75 mg as a single daily dose. Non-ST segment elevation acute coronary syndrome Initiate treatment w/ a single 300-mg loading dose & then continued at 75 mg once daily (w/ ASA 75-325 mg daily). ST segment elevation acute MI Initiate treatment w/ a 300-mg loading dose w/ ASA & then continued at 75 mg once daily.

Class:

          Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Presentation/Packing:

          Plavix film-coated tablet - Plavix 75 mg x 14's

Details:

          MyPhuocPharmacy – (08) 62581003